Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin for Esophageal or Invasive Candidiasis in Chinese Adults
NCT00635648Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2008
- Primary completion
- May 2011
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 3 trial of caspofungin in esophageal candidiasis, invasive candidiasis, sponsored by Merck & Co.. Started Jan 2008; status: completed.
02
Drugs
caspofungin
03
Conditions
esophageal candidiasisinvasive candidiasis
Beyond the preview
Go deeper on NCT00635648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635648.